Licensing-out

ELPEN has extended its activities to include licensing-out of generic products, developed internally. Link product list 2011

 
In addition to the extensive generic portfolio offered, ELPEN is presently in the position to discuss licensing-out opportunities for its new, patented worldwide, Dry Powder Inhaler device: ELPENHALER®.

For inquiries relating to the ELPENHALER® please contact us at  bdelpenhaler@elpen.gr

Home |Sitemap|Career|Legal Notice|Experimental & Research |Contact
2009-2012 ELPEN | created by PharmaComm, all rights reserved.